| Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation KJ Ewer, GA O’Hara, CJA Duncan, KA Collins, SH Sheehy, ... Nature communications 4 (1), 2836, 2013 | 375 | 2013 |
| Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA− NP+ M1 TK Berthoud, M Hamill, PJ Lillie, L Hwenda, KA Collins, KJ Ewer, A Milicic, ... Clinical infectious diseases 52 (1), 1-7, 2011 | 355 | 2011 |
| Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector GA O’Hara, CJA Duncan, KJ Ewer, KA Collins, SC Elias, FD Halstead, ... Journal of Infectious Diseases 205 (5), 772-781, 2012 | 266 | 2012 |
| ChAd63-MVA–vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans SH Sheehy, CJA Duncan, SC Elias, P Choudhary, S Biswas, FD Halstead, ... Molecular Therapy 20 (12), 2355-2368, 2012 | 256 | 2012 |
| Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine KA Collins, R Snaith, MG Cottingham, SC Gilbert, AVS Hill Scientific reports 7 (1), 46621, 2017 | 237 | 2017 |
| Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors SH Sheehy, CJA Duncan, SC Elias, KA Collins, KJ Ewer, AJ Spencer, ... Molecular Therapy 19 (12), 2269-2276, 2011 | 207 | 2011 |
| Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors SH Sheehy, CJA Duncan, SC Elias, S Biswas, KA Collins, GA O'Hara, ... PloS one 7 (2), e31208, 2012 | 199 | 2012 |
| Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals SH Hodgson, KJ Ewer, CM Bliss, NJ Edwards, T Rampling, ... The Journal of infectious diseases 211 (7), 1076-1086, 2015 | 164 | 2015 |
| A controlled human malaria infection model enabling evaluation of transmission-blocking interventions KA Collins, CYT Wang, M Adams, H Mitchell, M Rampton, S Elliott, ... The Journal of clinical investigation 128 (4), 1551-1562, 2018 | 117 | 2018 |
| Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+ CPG 7909 CJA Duncan, SH Sheehy, KJ Ewer, AD Douglas, KA Collins, FD Halstead, ... PloS one 6 (7), e22271, 2011 | 109 | 2011 |
| Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and … C Ogwang, M Afolabi, D Kimani, YJ Jagne, SH Sheehy, CM Bliss, ... PLoS One 8 (3), e57726, 2013 | 104 | 2013 |
| A randomized feasibility trial comparing four antimalarial drug regimens to induce Plasmodium falciparum gametocytemia in the controlled human malaria infection … IJ Reuling, LA Van De Schans, LE Coffeng, K Lanke, L Meerstein-Kessel, ... Elife 7, e31549, 2018 | 77 | 2018 |
| Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure S Biswas, P Choudhary, SC Elias, K Miura, KH Milne, SC de Cassan, ... PloS one 9 (9), e107903, 2014 | 75 | 2014 |
| Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations D Kimani, YJ Jagne, M Cox, E Kimani, CM Bliss, E Gitau, C Ogwang, ... Molecular Therapy 22 (11), 1992-2003, 2014 | 73 | 2014 |
| Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice GM Warimwe, G Lorenzo, E Lopez-Gil, A Reyes-Sandoval, ... Virology journal 10 (1), 349, 2013 | 71 | 2013 |
| A multiplex assay for the sensitive detection and quantification of male and female Plasmodium falciparum gametocytes L Meerstein-Kessel, C Andolina, E Carrio, A Mahamar, P Sawa, ... Malaria journal 17, 1-11, 2018 | 63 | 2018 |
| Combining liver-and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference EK Forbes, S Biswas, KA Collins, SC Gilbert, AVS Hill, SJ Draper The Journal of Immunology 187 (7), 3738-3750, 2011 | 57 | 2011 |
| Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models AM Salman, E Montoya-Díaz, H West, A Lall, E Atcheson, ... Scientific reports 7 (1), 46482, 2017 | 52 | 2017 |
| Analysis of human B‐cell responses following C h A d63‐MVA MSP 1 and AMA 1 immunization and controlled malaria infection SC Elias, P Choudhary, SC de Cassan, S Biswas, KA Collins, ... Immunology 141 (4), 628-644, 2014 | 51 | 2014 |
| A phase 1, placebo-controlled, randomized, single ascending dose study and a volunteer infection study to characterize the safety, pharmacokinetics, and antimalarial activity … JS McCarthy, C Donini, S Chalon, J Woodford, L Marquart, KA Collins, ... Clinical Infectious Diseases 71 (10), e657-e664, 2020 | 48 | 2020 |
